Cancer research
A recent study published in the Journal of Robotic Surgery has shed light on the impact of various clinical and surgical factors on the occurrence of postoperative complications in elderly patients with colorectal cancer. The research, conducted at the Second Xiangya Hospital of Central South University, aimed to assess the
Cancer research
Researchers at Central South University in Changsha, People's Republic of China, have found that the anti-EGFR antibody A140, combined with chemotherapy, is equivalent to cetuximab in the treatment of first-line RAS wild-type metastatic colorectal cancer (mCRC). The study, published in the European Journal of Cancer, involved 688 patients
Cancer research
Researchers at Fudan University Shanghai Cancer Center have discovered a new predictive tool for personalized therapy in colorectal cancer (CRC) patients. By analyzing the methylation status of septin 9 (mSEPT9), a research team led by Han Shan was able to identify a significant association between mSEPT9 positivity and clinicopathological characteristics
Cancer research
Akeso, Inc. has achieved a significant milestone in the fight against gastric cancer, enrolling and dosing the first patient in the pivotal Phase III clinical trial (AK104-310/COMPASSION-33) evaluating cadonilimab for the perioperative treatment of resectable gastric/gastroesophageal junction (G/GEJ) adenocarcinoma. This study aims to improve radical resection rates,
Cancer research
Malnutrition remains a significant concern for critically ill patients, especially those undergoing gastrointestinal surgery. Researchers at University Gadjah Mada in Yogyakarta, Indonesia have highlighted the importance of adequate nutritional therapy in preventing malnutrition in such cases. A recent study published in Jurnal Anestesiologi Indonesia, the official journal of the Faculty
Cancer research
A new study from Chang Gung Memorial Hospital Linkou in Taoyuan, Taiwan, has shed light on the effects of metformin on rectal cancer patients undergoing neoadjuvant chemoradiotherapy. The research, published in Scientific Reports, involved a retrospective analysis of 89 patients with locally advanced rectal cancer, of whom 56 were metformin
Cancer research
Research conducted at Beni Suef University in Egypt has highlighted the potential of lipid nanoparticles (LNPs) in delivering nucleic acid therapy for cancer treatment. According to the study, LNPs can safely and efficiently deliver therapeutic molecules directly to immune cells, enhancing their bioavailability and therapeutic impact. The use of LNPs
Cancer research
The development of a new robotic radial endobronchial ultrasound system for visualizing and localizing lung lesions or nodules is poised to revolutionize the diagnosis and treatment of lung cancer. The patented system, invented by Christopher Manley, utilizes a guide sheath, flexible bronchoscope, and radial endobronchial ultrasound probe to provide a
Cancer research
A recent study published in the August 2025 edition of Medicine has shed light on the issue of colorectal cancer (CRC) screening within the Veterans Health Administration (VA). The research, conducted by a team of scientists from New York University (NYU), aimed to examine the predictors of CRC and the
Cancer research
According to a recent study published in Anticancer Research, investigators at the University of Lubeck have developed a risk score for radiation pneumonitis (RP) in elderly lung cancer patients. This score was compared to an existing tool created for patients of any age and was found to be highly accurate
Cancer research
Investigating the relationship between Omega-3 fatty acid intake and the risk of prostate cancer, a recent study published in Frontiers in Nutrition has found a linear relationship between the two. While the study suggests that higher intakes of Omega-3 fatty acids may slow prostate cancer progression and reduce mortality risk,
Cancer research
A study published in Blood Advances has investigated the treatment patterns and clinical outcomes for patients with mantle cell lymphoma who experienced progression-of-disease (POD) following CD19-directed chimeric antigen receptor T-cell (CAR-T) therapy. The research identified 135 patients (35% of 384 total patients) who experienced POD, with most patients (64%) having
